Abstract
Because Alzheimer's disease (AD) is a medical problem characterized by progressive loss of memory and cognition that is associated with a deficient cholinergic system, this work aims to evaluate some p-aminobenzoic acid (PABA) derivatives as acetylcholinesterase inhibitors in vitro, in continuation with our last studies. The assayed compounds are low toxic, simple-structured and low cost.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 732-735 |
| Number of pages | 4 |
| Journal | European Journal of Medicinal Chemistry |
| Volume | 40 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2005 |
Bibliographical note
Funding Information:The authors thank CONACYT and CGPI for financial support. L.M.E.F. thanks the Ministry of Education of the Slovak Republic for the fellowship granted during the academic year 2003–2004.
Keywords
- Acetylcholine
- Acetylcholinesterase
- Amides
- Enzymatic inhibitors
- Imides
- Molecular docking